Search

everythinglearnresearchcommunity

for

Search:↓

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

TNF-alpha inhibitors can cause various immune-related skin issues.

Iron deficiency is the main cause of hair loss in women, and iron supplements started within 6 months can improve hair health.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Ban Tu Wan, a Chinese herbal supplement, can cause severe liver damage.

Carbamazepine may cause lung problems and lupus-like symptoms, which can improve after stopping the drug.

Antiviral medication valganciclovir may improve skin and hair in Trichodysplasia Spinulosa patients.

The document concludes that new treatments for skin conditions are complex but effective, including spironolactone for female hair loss and propranolol for infantile hemangiomas.

Volatile organic compounds can cause inflammation and increase the risk of autoimmune diseases.

A patient with a nerve disorder died from infection complications after developing insulin resistance from a treatment.

Autoimmune skin disorders are caused by genetic and environmental factors and are treated with various medications and preventative strategies.

Higher miR-34a levels and the A variant of the MIR-34A gene are linked to increased risk and severity of alopecia areata.

Vitiligo affects overall health and self-esteem, needing more research and awareness.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

Dietary lipids affect inflammation and are crucial for normal cell function and immune health.

Hydralazine and minoxidil are blood pressure medications that relax blood vessels, with potential side effects like rapid heartbeat and fluid retention, and are used for severe or pregnancy-related hypertension.

Cyclophosphamide often causes gastrointestinal issues, hair loss, and low blood cell counts in Chinese patients with autoimmune diseases.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Most clinicians follow discharge guidelines, many lupus patients don't use sunscreen regularly, dithranol is effective for psoriasis, biopsy methods should be based on lesion type, voriconazole may raise skin cancer risk, a new scale can help diagnose female hair loss early, and most melanomas may develop from existing moles.

Hair changes can indicate systemic diseases or medication effects.

A mutation in the IKZF1 gene causes immune system overactivity, linked to autoimmune diseases like lupus.

Skin and hair changes in horses can indicate serious diseases, and recognizing these signs is important for treatment and management.

Syphilis should be considered if PLEVA-like symptoms don't improve with treatment.

Breast implants are linked to autoimmune symptoms, with over half of patients feeling better after removal, but the exact cause is unclear and may involve bacterial biofilm.

Acitretin is effective for severe skin conditions but has significant side effects and requires careful monitoring.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

The most effective treatments for hair loss are minoxidil, finasteride, PRP, and hair transplants, with steroids and immunosuppressants for autoimmune types.

Anti-complement agents could effectively treat autoimmune diseases with fewer side effects.

The document concludes that reactivation of herpesviruses, especially HHV-6, is linked to severe symptoms and complications in drug-induced hypersensitivity syndrome.

Low DHEA-S levels might be linked to alopecia areata and could be a potential treatment target.